Scancell Holdings PLC (SCLP)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
9.00p
Buy
9.50p
-0.35p (-3.68%)
Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
Prices updated at 13 May 2025, 14:34 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Ms. Susan Elizabeth Clement-Davies
CEO
Dr. Philip John L'Huillier
Most recent earnings
30 Apr 2024
Fiscal year end
30 Apr 2024
Employees
58
Head office
Sanders Road
Oxford
United Kingdom
OX4 4GD
Key personnel
Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
---|---|---|---|---|---|
Ms. Susan Elizabeth Clement-Davies Non-Executive Director, Deputy Chairman | - | - | - | - | - |
Mr. Martin Henry Diggle Non-Executive Director | - | - | - | - | - |
Mr. Sath Nirmalananthan Executive Director, Chief Financial Officer | - | - | - | - | - |
Dr. Philip John L'Huillier Executive Director, Chief Executive Officer | - | - | - | - | - |
Top 5 shareholders
Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
---|---|---|---|---|---|---|
AXA Investment Managers UK Ltd | 24,294,856 | 0.58394 | - | - | 30 Apr 2025 | 2.61 |
UTM IM GBP AXA Framlington Biotech | 24,294,856 | 0.58394 | - | - | 30 Apr 2025 | 2.61 |
Calculus Capital Limited | 2,531,034 | 0.88624 | -25063 | - | 30 Apr 2025 | 0.27 |
Calculus VCT | 2,531,034 | 0.88624 | -25063 | -0.980518 | 30 Apr 2025 | 0.27 |
AXA Investment Managers Paris S.A. | 1,019,315 | 0.61453 | 9531 | - | 30 Apr 2025 | 0.11 |
Director dealings
Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
---|---|---|---|---|---|---|---|
10 Dec 2024 | Purchase | Mr. Sath Nirmalananthan | 10.50 | 20,000 | 190,476 | 0.02 | Placing |
Please note that past performance is not a reliable indicator of future returns.